2022 Q4 Form 10-K Financial Statement

#000121390023021418 Filed on March 20, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $153.7K $923.3K
YoY Change 47.85% 788.23%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $203.7K $1.123M
YoY Change -9.39% 393.03%
Operating Profit -$1.123M
YoY Change
Interest Expense $10.00 $70.00
YoY Change 0.0% 600.0%
% of Operating Profit
Other Income/Expense, Net $2.585M $4.410M
YoY Change 81974.92% 139899.68%
Pretax Income $2.382M $3.287M
YoY Change -1174.57% -1562.92%
Income Tax $500.9K $858.7K
% Of Pretax Income 21.03% 26.13%
Net Earnings $1.881M $2.428M
YoY Change -948.57% -1180.71%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.04 $0.06
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $409.7K $409.7K
YoY Change -48.19% -48.19%
Cash & Equivalents $409.7K
Short-Term Investments
Other Short-Term Assets $244.7K $244.7K
YoY Change -54.15% -54.15%
Inventory
Prepaid Expenses $244.7K
Receivables
Other Receivables
Total Short-Term Assets $654.4K $654.4K
YoY Change -50.59% -50.59%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $309.7M $309.7M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $309.7M $309.7M
YoY Change 1.22% 1.22%
TOTAL ASSETS
Total Short-Term Assets $654.4K $654.4K
Total Long-Term Assets $309.7M $309.7M
Total Assets $310.4M $310.4M
YoY Change 1.0% 1.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $552.1K $552.1K
YoY Change 81.13% 81.13%
Accrued Expenses $100.9K $100.9K
YoY Change -26.24% 683.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.096M $1.096M
YoY Change 142.07% 142.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.20M $11.20M
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $11.20M $11.20M
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.096M $1.096M
Total Long-Term Liabilities $11.20M $11.20M
Total Liabilities $12.30M $12.30M
YoY Change 5.52% 5.52%
SHAREHOLDERS EQUITY
Retained Earnings -$10.43M
YoY Change 7.22%
Common Stock $135.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$11.03M $298.1M
YoY Change
Total Liabilities & Shareholders Equity $310.4M $310.4M
YoY Change 1.0% 1.0%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $1.881M $2.428M
YoY Change -948.57% -1180.71%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$435.4K -$1.050M
YoY Change -26.61% 76.96%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $378.8K $668.9K
YoY Change -100.12% -100.22%
Cash From Investing Activities $378.8K $668.9K
YoY Change -100.12% -100.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -435.4K -$1.050M
Cash From Investing Activities 378.8K $668.9K
Cash From Financing Activities 0.000
Net Change In Cash -56.66K -$381.0K
YoY Change -107.4% -148.19%
FREE CASH FLOW
Cash From Operating Activities -$435.4K -$1.050M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41076
CY2022 dei Entity Registrant Name
EntityRegistrantName
ShoulderUp Technology Acquisition Corp.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-1730135
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
125 Townpark Drive
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 3000
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Kennesaw
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30144
CY2022 dei City Area Code
CityAreaCode
(970)
CY2022 dei Local Phone Number
LocalPhoneNumber
924-0446
CY2022 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.0001 per share
CY2022 dei Trading Symbol
TradingSymbol
SUAC
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
297600000 usd
CY2022 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2022 dei Auditor Location
AuditorLocation
New York
CY2022 dei Auditor Firm
AuditorFirmId
100
CY2022Q4 us-gaap Cash
Cash
409725 usd
CY2021Q4 us-gaap Cash
Cash
790770 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
244688 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
533677 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
654413 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1324447 usd
CY2022Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
309744280 usd
CY2021Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
306003154 usd
CY2022Q4 us-gaap Assets
Assets
310398693 usd
CY2021Q4 us-gaap Assets
Assets
307327601 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
552059 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
304778 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12874 usd
CY2022Q4 suac Franchise Tax Payable
FranchiseTaxPayable
100882 usd
CY2021Q4 suac Franchise Tax Payable
FranchiseTaxPayable
123886 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
414724 usd
CY2022Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
28043 usd
CY2021Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
11098 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1095708 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
452636 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
11200000 usd
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
11200000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
12295708 usd
CY2021Q4 us-gaap Liabilities
Liabilities
11652636 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
309130532 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
306000000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
135 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
135 usd
CY2022Q4 suac Common Stock Value One
CommonStockValueOne
1045 usd
CY2021Q4 suac Common Stock Value One
CommonStockValueOne
1045 usd
CY2022Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
600000 usd
CY2021Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
600000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10428727 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9726215 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11027547 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-10325035 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
310398693 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
307327601 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
923313 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
103950 usd
CY2022 us-gaap Production Tax Expense
ProductionTaxExpense
200000 usd
us-gaap Production Tax Expense
ProductionTaxExpense
123886 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1123313 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-227836 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
70 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
14 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
4409987 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
3154 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3286744 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-224668 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
858724 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2428020 usd
us-gaap Net Income Loss
NetIncomeLoss
-224668 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
13350000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
12900000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
779246 usd
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
35596121 usd
us-gaap Net Income Loss
NetIncomeLoss
-224668 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-10325035 usd
CY2022 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-3130532 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2428020 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-11027547 usd
CY2022 us-gaap Profit Loss
ProfitLoss
2428020 usd
us-gaap Profit Loss
ProfitLoss
-224668 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
1516 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
4409987 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
3154 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-288989 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
533677 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
247281 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
23928 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12874 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
18874 usd
CY2022 suac Increase Decrease Franchise Tax Payable
IncreaseDecreaseFranchiseTaxPayable
23004 usd
suac Increase Decrease Franchise Tax Payable
IncreaseDecreaseFranchiseTaxPayable
-123886 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
414724 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
16944 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1049907 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-593295 usd
CY2022 us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
668862 usd
suac Cash Deposited In Trust Account
CashDepositedInTrustAccount
-306000000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
668862 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-306000000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
23840 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
300000000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
12900000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
5517095 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
307384065 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-381045 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
790770 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
790770 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
409725 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
790770 usd
suac Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
280850 usd
suac Offering Costs Paid By Related Party
OfferingCostsPaidByRelatedParty
27423 usd
us-gaap Stock Issued1
StockIssued1
11200000 usd
us-gaap Notes Issued1
NotesIssued1
600000 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
444000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 suac Public Offering Shares
PublicOfferingShares
30000000 shares
CY2021Q4 suac Underwriting Shares
UnderwritingShares
3500000 shares
CY2021Q4 suac Public Offering Per Shares
PublicOfferingPerShares
10
CY2021Q4 suac Gross Proceeds
GrossProceeds
300000000 usd
CY2022Q4 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
17820368 usd
CY2022 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
5300000 usd
CY2022 suac Deferred Underwriting Commissions
DeferredUnderwritingCommissions
11200000 usd
CY2022Q4 us-gaap Other Ownership Interests Offering Costs
OtherOwnershipInterestsOfferingCosts
1320368 usd
CY2022Q4 suac Offering Costs
OfferingCosts
795000 usd
CY2022 suac Aggregate Fair Value
AggregateFairValue
0.80 pure
CY2022 suac Outstanding Vote Percentage
OutstandingVotePercentage
0.50 pure
CY2021Q4 suac Public Per Share
PublicPerShare
10.2
CY2022 suac Public Shares Percentage
PublicSharesPercentage
1 pure
CY2022 suac Trust Account Per Share
TrustAccountPerShare
10.2
CY2022 suac Sponsor Support Agreement Description
SponsorSupportAgreementDescription
The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.20 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act.
CY2022Q4 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
400000 usd
CY2022 suac Working Capital Deficit
WorkingCapitalDeficit
400000 usd
CY2022 suac Subscription Receivable
SubscriptionReceivable
600000 usd
CY2022Q4 suac Founder Share
FounderShare
25000 usd
CY2022Q4 us-gaap Variable Interest Difference Between Carrying Amount And Maximum Exposure
VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure
29000 usd
CY2022 suac Repayment Amount
RepaymentAmount
24000 usd
CY2022 suac Remains Outstanding
RemainsOutstanding
5000 usd
CY2022Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
306000000 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
1656890 usd
CY2022 suac Federal Excise Tax Percentage
FederalExciseTaxPercentage
0.01 pure
CY2022 suac Fair Market Value Precentage
FairMarketValuePrecentage
0.01 pure
CY2021Q3 suac Founder Shares Description
FounderSharesDescription
the Sponsor paid $25,000 in consideration for 9,833,333 Founder Shares. Up to 1,250,000 Founder Shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. In November 2021, the Company effected a 1.0627119 for 1 stock split of the Class B common stock, so that the Sponsor owns an aggregate of 10,450,000 Founder Shares. Up to 1,190,000 of the Founder Shares would have been forfeited depending on the extent to which the underwriters’ over-allotment option is not exercised.
CY2021Q4 suac Forfeiture Shares
ForfeitureShares
1190000 shares
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company's financial condition, results of operations, and cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
CY2022 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2021Q3 us-gaap Other Expenses
OtherExpenses
300000 usd
CY2022 us-gaap Deconsolidation Related Party Description
DeconsolidationRelatedPartyDescription
In connection with the IPO, the Sponsor had advanced to the Company an aggregate of approximately $29,000, of which approximately $24,000 was repaid to the Sponsor upon the closing of the IPO. As of December 31, 2022 and 2021, approximately $5,000, remained outstanding and is due on demand, and is included in the due to related party on the accompanying balance sheets.
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
23000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
6000 usd
CY2022Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
30000000 shares
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
30000000 shares
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
30000000 shares
CY2021Q4 suac Underwriters Option To Purchase
UnderwritersOptionToPurchase
3500000 shares
CY2021Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10
CY2021Q4 us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
Each Unit consists of one share of Class A common stock and one-half redeemable warrant.
CY2021Q4 suac Maturity Term
MaturityTerm
P185D
CY2022 suac Proceeds From Private Units
ProceedsFromPrivateUnits
1350000 shares
CY2022 suac Price Per Share
PricePerShare
10
CY2022Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
600000 usd
CY2021Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
600000 usd
CY2022 suac Private Unit Description
PrivateUnitDescription
Each Private Unit consists of one share of Class A common stock and one-half of one warrant. Each whole warrant is exercisable to purchase one whole share of Class A common stock at $11.50 per share.
CY2022Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1500000 usd
CY2021Q4 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
10000 usd
CY2022 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
120000 usd
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
14000 usd
CY2022 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
23000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
6000 usd
CY2021Q4 us-gaap Other Underwriting Expense
OtherUnderwritingExpense
5300000 usd
CY2022 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
300000000 usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
13350000 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-16246121 usd
CY2022Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
35596121 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
306000000 usd
CY2022 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
3130532 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
309130532 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022 us-gaap Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
P5Y
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Class Of Warrant Or Right Reason For Issuing To Nonemployees
ClassOfWarrantOrRightReasonForIssuingToNonemployees
Once the warrants become exercisable, the Company may redeem the outstanding warrants:  ●in whole and not in part;   ●at a price of $0.01 per warrant;   ●upon a minimum of 30 days’ prior written notice of redemption (the 30-day redemption period); and   ●if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.  
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
884112 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-193896 usd
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-21830 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
168508 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
21830 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
858724 usd
CY2022Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
215796 usd
CY2021Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
21830 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
25351 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
215796 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
47181 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
215796 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47181 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 suac Effective Income Tax Rate Reconciliation Change In Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInValuationAllowance
0.051 pure
CY2021 suac Effective Income Tax Rate Reconciliation Change In Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInValuationAllowance
-0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.261 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0 pure
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2022 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
usd
CY2022 suac Cash Deposited In Trust Account
CashDepositedInTrustAccount
usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2022 suac Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
usd
CY2022 suac Offering Costs Paid By Related Party
OfferingCostsPaidByRelatedParty
usd
CY2022 us-gaap Stock Issued1
StockIssued1
usd
CY2022 us-gaap Notes Issued1
NotesIssued1
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001885461

Files In Submission

Name View Source Status
0001213900-23-021418-index-headers.html Edgar Link pending
0001213900-23-021418-index.html Edgar Link pending
0001213900-23-021418.txt Edgar Link pending
0001213900-23-021418-xbrl.zip Edgar Link pending
f10k2022ex31-1_shoulderup.htm Edgar Link pending
f10k2022ex31-2_shoulderup.htm Edgar Link pending
f10k2022ex32-1_shoulderup.htm Edgar Link pending
f10k2022ex32-2_shoulderup.htm Edgar Link pending
f10k2022ex4-5_shoulderup.htm Edgar Link pending
f10k2022_shoulderup.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
f10k2022_shoulderup_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
suac-20221231.xsd Edgar Link pending
suac-20221231_def.xml Edgar Link unprocessable
suac-20221231_cal.xml Edgar Link unprocessable
suac-20221231_lab.xml Edgar Link unprocessable
suac-20221231_pre.xml Edgar Link unprocessable